Anthem Biosciences IPO GMP Today! Why Are People Buying?

Anthem Biosciences’ IPO shows strong pre-listing momentum with a ₹144–₹154 GMP, driven by heavy institutional demand, robust financials, and sector leadership in CRDMO. Investors anticipate 25–27% listing gains.

2025-07-17Read

What is Anthem Biosciences? Analyzing the IPO

Anthem Biosciences IPO at ₹540–₹570 shows promise with strong growth, global clients, and ₹156 GMP. Valuation’s high, but growth believers may still see value.

2025-07-16Read

• 1